West Windsor, NJ, United States of America

Prasanna Sunthankar

This inventor holds 10 USPTO granted patents and 8 published patent applications, plus 3 CIPO patents and 2 EPO patents. Top assignees: Nortic Holdings Inc., Acasti Pharma U.s., Inc., Grace Therapeutics Inc.. Active years: 2018-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Prasanna Sunthankar. Retrieved from https://idiyas.com/inventor/prasanna-sunthankar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 4.5

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2018-2025

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: **Prasanna Sunthankar: A Visionary Inventor in Pharmaceutical Innovations**

Introduction

Prasanna Sunthankar, located in West Windsor, NJ, has made significant contributions to the field of pharmaceuticals as an inventor with a total of 8 patents to his name. His innovative work focuses on formulations that are both effective and stable, addressing critical needs in medical treatments.

Latest Patents

Sunthankar's latest patents showcase his expertise in developing formulations that enhance patient care. One of his notable inventions is the "Stable Nimodipine Parenteral Formulation." This nimodipine injection concentrate is designed to be an aqueous solution that is substantially free of organic solvents, ensuring that it remains stable and clear. This formulation utilizes a hydrophilic surfactant, specifically polysorbate 80, allowing nimodipine to be effectively contained as a concentrated solution, suspension, emulsion, or colloidal particle.

Another significant patent is the "Therapeutic Composition of Intranasal Lidocaine." This nasal spray formulation acts as a locally-acting sodium channel blocker for treating pain. It consists of a specific concentration of the sodium channel blocker, a buffering agent, and a pharmaceutically acceptable carrier for nasal administration. The innovative design includes a mechanical multi-dose pump that delivers a unit dose efficiently, ensuring effective administration without the use of preservatives.

Career Highlights

Throughout his career, Prasanna Sunthankar has collaborated with companies such as Nortic Holdings Inc. and Acasti Pharma U.S., Inc. His work in these organizations has propelled advancements in pharmaceutical formulations and underscores his commitment to improving medical treatments through innovation.

Collaborations

Sunthankar has worked alongside notable professionals in the industry, including S. George Kottayil and Amresh Kumar. These collaborations have contributed to the development of his patents and have strengthened the impact of his research on the pharmaceutical landscape.

Conclusion

Prasanna Sunthankar exemplifies the role of inventors in advancing healthcare through innovative pharmaceutical solutions. His patents reflect a dedication to creating effective and stable formulations that can significantly enhance patient care. As he continues to develop groundbreaking inventions, his contributions are sure to leave a lasting legacy in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…